BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences - 21 News Now, More Local News for Youngstown, Ohio -

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE BioSpecifics Technologies Corp.

LYNBROOK, N.Y., May 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that BioSpecifics' President, Tom Wegman, will present at the following upcoming investor conferences.

  • 2014 UBS Global Healthcare Conference (New York, NY)
    Monday, May 19, 2014 at 9:30 a.m. EDT
  • Jefferies 2014 Global Healthcare Conference (New York, NY)
    Monday, June 2, 2014 at 2:00 p.m. EDT

The live webcasts of these presentations can be accessed under "Events and Presentation" in the Investors section of the Company's website at www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. Injectable collagenase is approved for marketing as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord in the palm and for Peyronie's disease in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy by BioSpecifics' partner, Auxilium Pharmaceuticals, Inc. (Auxilium). Auxilium is partnered with Actelion Pharmaceuticals Ltd. for the marketing of XIAFLEX in Canada and Australia, and Swedish Orphan Biovitrium AB for the marketing of XIAPEX® (the EU tradename for CCH) in 71 Eurasian and African countries for the treatment of Dupuytren's contracture, and Peyronie's disease pending applicable regulatory approvals. CCH is in clinical development for the treatment of several additional promising indications. Auxilium is testing CCH for frozen shoulder syndrome in a Phase 2b study and also for cellulite in a Phase 2a study. BioSpecifics is currently managing the development of CCH for the treatment of human and canine lipomas. For more information, please visit www.biospecifics.com.

©2012 PR Newswire. All Rights Reserved.

  • More From wfmj.comMore>>

  • US employers add 209K jobs, rate rises to 6.2 pct.

    US employers add 209K jobs, rate rises to 6.2 pct.

    Friday, August 1 2014 11:23 AM EDT2014-08-01 15:23:51 GMT
    U.S. employers extended this year's hiring surge into July by adding a solid 209,000 jobs. It was the sixth straight month of job growth above 200,000, evidence that businesses are shedding the caution that had...More >>
    U.S. employers extended their solid hiring into July by adding 209,000 jobs. It was the sixth straight month of job growth above 200,000, evidence that businesses are gradually shedding the caution that had marked the...More >>
  • GM boosted June sales with discounts to dealers

    GM boosted June sales with discounts to dealers

    Friday, August 1 2014 9:42 AM EDT2014-08-01 13:42:40 GMT
    By TOM KRISHER Associated Press Auto Writer As General Motors prepares to report monthly sales results on Friday, a look its numbers from June show just how intent the company is on keeping...More >>
    By TOM KRISHER Associated Press Auto Writer As General Motors tackles a safety crisis, a look its numbers from June show just how intent the company is on keeping new-car sales on the rise during a record...More >>
  • Group: homeless assaults should be hate crimes

    Group: homeless assaults should be hate crimes

    Friday, August 1 2014 9:23 AM EDT2014-08-01 13:23:08 GMT
    CINCINNATI (AP) - A southwest Ohio homeless advocacy group wants assaults on homeless people to be considered hate crimes under the law. The Greater Cincinnati Homeless Coalition says the designation of homeless people as a protected group would enhance penalties for offenders and help deter attacks. The Cincinnati Enquirer reports that homeless coalition executive director Josh Spring says the proposal comes on the heels of the beating of a homeless man last weekend. Spring said one of the t...More >>
    CINCINNATI (AP) - A southwest Ohio homeless advocacy group wants assaults on homeless people to be considered hate crimes under the law. The Greater Cincinnati Homeless Coalition says the designation of homeless people as a protected group would enhance penalties for offenders and help deter attacks. The Cincinnati Enquirer reports that homeless coalition executive director Josh Spring says the proposal comes on the heels of the beating of a homeless man last weekend. Spring said one of the t...More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 Worldnow and WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms